z-logo
open-access-imgOpen Access
Impact of levosimendan and ischaemia–reperfusion injury on myocardial subsarcolemmal mitochondrial respiratory chain, mitochondrial membrane potential, Ca2+cycling and ATP synthesis
Author(s) -
Stefanie Sommer,
M. Leistner,
Ivan Aleksić,
Christoph Schimmer,
K. Alhussini,
Peer Kanofsky,
Rainer Leyh,
Sebastian-Patrick Sommer
Publication year - 2015
Publication title -
european journal of cardio-thoracic surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.303
H-Index - 133
eISSN - 1873-734X
pISSN - 1010-7940
DOI - 10.1093/ejcts/ezv397
Subject(s) - levosimendan , mitochondrial permeability transition pore , contractility , perfusion , cardiology , medicine , ventricular pressure , chemistry , ischemia , respiratory chain , mptp , mitochondrion , hemodynamics , heart failure , biochemistry , apoptosis , programmed cell death , dopaminergic , dopamine
Levosimendan (LS) is increasingly used in case of myocardial failure after cardiac surgery. The impact of LS on myocardial mitochondrial functions, such as respiratory chain function (RCF), mitochondrial membrane potential (ΔΨm), Ca(2+) handling, mitochondrial permeability transition pore (mPTP) opening and ATP during ongoing ischaemia/reperfusion (IR) injury, is not well understood. Depending on LS, I/R injury or the combination of both, we analysed myocardial functions in a retrograde Langendorff-model followed by the analysis of subsarcolemmal mitochondrial (SSM) functions.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom